Corroborating our findings in mESCs, differential expression of other MMR genes (such as MLH3, MSH2, and PMS2) had no effect on overall survival of breast cancer patients (Supplemental Figure 3, C–E). This evidence concerns the gene PMS2 and breast carcinoma.